Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $9.12B.
ENTERPRISE VALUE (EV)
$9.12B
Krystal Biotech, Inc.
Market Cap
$9.61B
Enterprise Value (EV)
$9.12B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.61B | $9.12B |
| Henry Schein, Inc. (HSIC)vs › | $9.65B | $13.31B |
| Vaxcyte, Inc. (PCVX)vs › | $9.45B | $9.38B |
| Insulet Corp. (PODD)vs › | $9.38B | $9.80B |
| Bruker Corporation (BRKR)vs › | $9.38B | $11.11B |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.00B | $10.69B |
| Molina Healthcare, Inc. (MOH)vs › | $10.01B | $8.98B |
| Repligen Corporation (RGEN)vs › | $10.06B | $10.14B |
| The Ensign Group, Inc. (ENSG)vs › | $10.16B | $12.15B |
| Align Technology, Inc. (ALGN)vs › | $10.19B | $9.21B |
Market Cap
$9.61B
Total Debt
$0.00
Cash
$496.30M
Enterprise Value
$9.12B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
